UMMS Affiliation

Division of Hematology and Oncology, Department of Medicine

Publication Date

2020-05-04

Document Type

Letter to the Editor

Disciplines

Health Services Administration | Hemic and Lymphatic Diseases | Infectious Disease | Neoplasms | Oncology | Virus Diseases

Abstract

Currently, the world is witnessing a health crisis in the form of COVID-19 pandemic. For oncologists, especially for stem cell transplant specialists, the stress is high to perform to their best of capability for their cancer patients. In general, the hematopoietic stem cell transplantation (HSCT) is a high-risk procedure. The novelty of the COVID-19 disease, lack of literature, absence of antiviral agent, and vaccine has added more uncertainty while preparing for and recovering from HSCT.

Keywords

COVID-19, pandemic, hematopoietic stem cell transplantation, oncologists, guidelines

Rights and Permissions

Copyright © Springer Nature Limited 2020. Publisher PDF posted after 6 month embargo as allowed by the publisher's self-archiving policy athttps://www.nature.com/bmt/authors-and-referees/open-access-self-archiving.

DOI of Published Version

10.1038/s41409-020-0913-6

Source

Sahu KK, Siddiqui AD, Cerny J. COVID-19 pandemic and impact on hematopoietic stem cell transplantation. Bone Marrow Transplant. 2020 May 4:1–3. doi: 10.1038/s41409-020-0913-6. Epub ahead of print. PMID: 32367075; PMCID: PMC7197237. Link to article on publisher's site

Journal/Book/Conference Title

Bone marrow transplantation

Related Resources

Link to Article in PubMed

PubMed ID

32367075

Available for download on Wednesday, November 04, 2020

Share

COinS